In 2018, SilverMill, LLC (“SilverMill”) and PNC Riverarch Capital partnered to leverage their collective experience to build a scalable lab supplies manufacturer and distributor focusing on life science research products and specialized chemical manufacturing capabilities. The resulting entity was TCP Analytical Holdings, LLC (“TCP Analytical”). Serving 9,000 clients with a 50,000 SKU product portfolio, TCP Analytical caters to life science and biopharmaceuticals sectors, academic and government labs, and food and beverage and industrial markets. Primarily headquartered in Charlotte, North Carolina, TCP Analytical has manufacturing facilities spanning the East Coast and Midwest of the United States and Canada.

SilverMill and PNC Riverarch Capital engaged G2 Capital Advisors (“G2”) as the buy-side advisor for TCP Analytical, with the mandate of identifying, sourcing, and activating complementary businesses that would extend its geographic footprint. G2’s work led to the acquisition of Lifecycle Biotechnologies, LP (“Lifecycle Biotechnologies”), a Texas-based leader in life sciences manufacturing. Founded in 1978, Lifecycle Biotechnologies produces raw materials and components for emerging bio-pharmaceutical, regenerative medicine, industrial life sciences, and cellular agricultural product manufacturers—building blocks for lifesaving and life-enhancing medical products used globally today. "Our partnership with Lifecycle Biotechnologies brings us new capabilities with high-value, sterile solutions, and it will also allow us to better serve our customers throughout the country through a new key location,” says Nate Meyer, President of Specialty Manufacturing at TCP. “Together, we are expanding our manufacturing capacity across state-of-the-art facilities and reinforcing our commitment to building a scalable lab supplies manufacturer with a focus on life science research products made here in the US.”

Since its inception, TCP Analytical has grown its Specialty Manufacturing and Life Science Distribution channels through the strategic acquisition of companies with unique manufacturing capabilities, strong customer value propositions, and attractive growth profiles. This approach has built strong, long-standing relationships with a diverse and global customer base. TCP Analytical continues to view acquisitions as a strategic priority and sought a value-added advisor to help them navigate the vast landscape of opportunities.